XATRAL XL Prolonged release tablets (2017)
Active ingredients: Alfuzosin
Product Name and Form
Xatral XL 10 mg prolonged release tablets.
Prolonged release tablet.
Round biconvex, three layer tablet: one white layer between two yellow layers.
Qualitative and Quantitative Composition
Each tablet contains 10mg alfuzosin hydrochloride.
Excipient: Hydrogenated castor oil
For a full list of excipients, see section 6.1.
Alfuzosin is an orally active quinazoline derivative. It is a selective, peripherally acting antagonist of postsynaptic alpha-1-adrenoceptors. In vitro pharmacological studies have documented the selectivity of alfuzosin for the alpha-1-adrenoreceptors located in the prostate, bladder base and prostatic urethra.
Hydrogenated Castor Oil
Yellow Ferric Oxide (E172)
Silica Colloidal Hydrated
Pack sizes and Marketing
Boxes with 10, 30, 50, 100 and 500 tablets in pvc/foil blister strips.
Not all pack sizes may be marketed.
Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
or trading as: Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
02 April 2009